Search

Your search keyword '"Trajkovic-Arsic, Marija"' showing total 42 results

Search Constraints

Start Over You searched for: Author "Trajkovic-Arsic, Marija" Remove constraint Author: "Trajkovic-Arsic, Marija" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
42 results on '"Trajkovic-Arsic, Marija"'

Search Results

1. Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

2. Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization

4. Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer

5. Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

6. Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.

8. Development of a LRRC15-Targeted Radio-Immunotheranostic Approach to Deplete Pro-tumorigenic Mechanisms and Immunotherapy Resistance

9. Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation

10. Minimally invasive determination of PDAC subtype and therapy-induced subtype switch by means of circulating cell-free RNA

11. MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

12. Author Correction: Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

13. Hyperpolarized 13C pyruvate magnetic resonance spectroscopy for in vivo metabolic phenotyping of rat HCC

15. The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma

16. Fibroblast Activation Protein-Targeted Photodynamic Therapy of Cancer-Associated Fibroblasts in Murine Models for Pancreatic Ductal Adenocarcinoma

17. Fibroblast Activation Protein-Targeting Minibody-IRDye700DX for Ablation of the Cancer-Associated Fibroblast with Photodynamic Therapy

18. Superior Tumor Detection for68Ga-FAPI-46 Versus18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

19. Figure S3 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

20. Supplementary Data DS1 from LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

21. Supplement from Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer

22. Data from Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

23. Figure S2 from Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting

27. LAMC2 regulates key transcriptional and targetable effectors to support pancreatic cancer growth

28. Dose‐dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9‐induced leukaemic cells.

29. LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

30. Additional file 1 of Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

31. Additional file 2 of Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

32. Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma.

33. Functional non-invasive detection of glycolytic pancreatic ductal adenocarcinoma

34. Epigenetic plasticity via adaptive DNA hypermethylation and clonal expansion underlie resistance to oncogenic pathway inhibition in pancreatic cancer

36. Is metabolism the magic bullet for targeted cancer therapy?

37. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

38. A FAP-targeting minibody-IRDye700DX for photodynamic therapy of the cancer associated fibroblast.

39. Fibroblast activation protein inhibitor (FAPI) Theranostics: Preclinical combination treatment

40. Fibroblast Activation Protein-Directed Imaging Outperforms 18 F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.

41. Histology-Based Radiomics for [ 18 F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer.

42. Superior Tumor Detection for 68 Ga-FAPI-46 Versus 18 F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma.

Catalog

Books, media, physical & digital resources